冯·希佩尔-林道综合征相关实性胰腺肿瘤CT筛查与监测策略的累积辐射暴露
该回顾性研究评估了747例冯·希佩尔-林道综合征患者接受腹部-盆腔或胸-腹-盆腔CT筛查与监测的辐射暴露,比较了三期与双能虚拟平扫协议及两种胰腺神经内分泌肿瘤监测算法。结果显示CT筛查可导致显著累积辐射剂量,而基于基因型与肿瘤直径的定制算法可能降低终生辐射暴露。
要点
- 双能虚拟平扫CT的结肠中位累积剂量低于三期CT(0.34 Gy vs 0.89 Gy,年龄15-40岁每年筛查)。
- 现行监测方案下,40-65岁累积有效剂量在肿瘤<1.2 cm者为682 mSv,>3 cm者为2125 mSv。
- 定制算法可使初始肿瘤直径<1.2 cm患者的累积剂量减半(P < .001)。
核心结论
- 冯·希佩尔-林道综合征患者的CT筛查可导致显著辐射暴露,即使采用双能虚拟平扫CT;基于基因型与肿瘤直径的算法可能降低胰腺神经内分泌肿瘤监测的终生辐射暴露。
研究设计与样本
- 回顾性研究,纳入2009至2015年美国国立卫生研究院临床中心747例冯·希佩尔-林道综合征患者(平均年龄47.6岁±14.6,范围12-83岁;女性320例[42.8%]),行腹部-盆腔或胸-腹-盆腔CT,采用三期协议(n=1242)或双能虚拟平扫协议(n=149);胰腺神经内分泌肿瘤患者124例共381次扫描,比较基于肿瘤直径的监测协议与基于VHL基因型和肿瘤直径的定制算法;由两名放射科医生和五名辐射科学家估算器官和终生辐射剂量;采用方差分析比较累积剂量,双侧P值<0.05为有统计学意义。
诊断标准与关键数值
- 从15岁至40岁每年行胸-腹-盆腔和腹部-盆腔CT的结肠中位累积剂量:双能虚拟平扫CT为0.34 Gy(第5-95百分位数0.18-0.75),三期CT为0.89 Gy(第5-95百分位数0.42-1.0)。现行胰腺神经内分泌肿瘤监测协议下,40岁至65岁累积有效剂量:肿瘤<1.2 cm者为682 mSv,肿瘤>3 cm者为2125 mSv。定制算法可使初始肿瘤直径<1.2 cm患者的累积剂量减半(P < .001)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To assess the potential ionizing radiation exposure from CT scans for both screening and surveillance of patients with von Hippel-Lindau (VHL) syndrome. Materials and Methods For this retrospective study, abdomen-pelvic (AP) and chest-abdomen-pelvic (CAP) CT scans were performed with either a three-phase (n = 1242) or a dual-energy virtual noncontrast protocol (VNC; n = 149) in 747 patients with VHL syndrome in the National Institutes of Health Clinical Center between 2009 and 2015 (mean age, 47.6 years ± 14.6 [standard deviation]; age range, 12-83 years; 320 women [42.8%]). CT scanning parameters for patients with pancreatic neuroendocrine tumors (PNETs; 124 patients and 381 scans) were compared between a tumor diameter-based surveillance protocol and a VHL genotype and tumor diameter-based algorithm (a tailored algorithm) developed by three VHL clinicians. Organ and lifetime radiation doses were estimated by two radiologists and five radiation scientists. Cumulative radiation doses were compared between the PNET surveillance algorithms by analyses of variance, and a two-tailed P value less than .05 indicated statistical significance. Results Median cumulative colon doses for annual CAP and AP CT scans from age 15 to 40 years ranged from 0.34 Gy (5th-95th percentiles, 0.18-0.75; dual-energy VNC CT) to 0.89 Gy (5th-95th percentiles, 0.42-1.0; three-phase CT). For the current PNET surveillance protocol, the cumulative effective radiation dose from age 40 to 65 years was 682 mSv (tumors < 1.2 cm) and 2125 mSv (tumors > 3 cm). The tailored algorithm could halve these doses for patients with initial tumor diameter less than 1.2 cm (P < .001). Conclusion CT screening of patients with von Hippel-Lindau syndrome can lead to substantial radiation exposures, even with dual-energy virtual noncontrast CT. A genome and tumor diameter-based algorithm for pancreatic neuroendocrine tumor surveillance may potentially reduce lifetime radiation exposure. © RSNA, 2018 Online supplemental material is available for this article.
引用
- Tirosh A, Journy N, Folio LR, et al. Cumulative Radiation Exposures from CT Screening and Surveillance Strategies for von Hippel-Lindau-associated Solid Pancreatic Tumors. Radiology. 2018. PMID: 30299237. doi:10.1148/radiol.2018180687
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。